
================================================================================
COMPREHENSIVE CRISPR SCREEN PROTOCOL: T CELL EXHAUSTION GENE IDENTIFICATION
================================================================================

SCREEN OBJECTIVE: Identify novel genes regulating T cell exhaustion through pooled CRISPR knockout screening

================================================================================
1. TARGET GENE SELECTION (32 GENES MAXIMIZING PERTURBATION EFFECT)
================================================================================
A. Core Checkpoint Molecules (8 genes)
   - PDCD1 (PD-1): Primary exhaustion marker
   - CTLA4: Competitive CD28 inhibitor
   - LAG3: CD3/TCR complex inhibitor
   - HAVCR2 (TIM-3): Galectin-9 receptor
   - TIGIT: CD226 competitive inhibitor
   - CD244 (2B4): SLAM family inhibitory receptor
   - CD160: HVEM ligand
   - PDCD1LG2 (PD-L2): PD-1 ligand

B. Transcription Factors (10 genes)
   - TOX: Master exhaustion TF
   - TOX2: TOX paralog
   - NR4A1, NR4A2, NR4A3: Nuclear receptors driving exhaustion
   - BATF: AP-1 family TF
   - IRF4: Interferon regulatory factor
   - MAF: c-Maf transcription factor
   - PRDM1 (BLIMP1): Terminal differentiation TF
   - RORA: RAR-related orphan receptor

C. Metabolic Regulators (8 genes)
   - ENTPD1 (CD39): ATP-to-AMP conversion
   - NT5E (CD73): AMP-to-adenosine conversion
   - ARG1: Arginine depletion
   - IDO1: Tryptophan depletion
   - PDHA1: Pyruvate metabolism
   - LDHA: Lactate production
   - PKM: Pyruvate kinase
   - SLC2A1 (GLUT1): Glucose transport

D. Epigenetic Modifiers (6 genes)
   - DNMT3A: DNA methylation
   - TET2: DNA demethylation
   - EZH2: H3K27me3 deposition
   - HDAC9: Histone deacetylation
   - KDM6B: H3K27me3 demethylation
   - BRD4: Chromatin reader

================================================================================
2. sgRNA LIBRARY DESIGN
================================================================================
- 4 sgRNAs per gene = 128 gene-targeting guides
- 10 non-targeting controls
- 5 safe-targeting controls (non-essential genes)
- Total library size: 143 guides

sgRNA Design Criteria:
- 20bp targeting sequence + GTTT scaffold
- BsmBI restriction sites for cloning
- High on-target activity (Doench 2016 score > 0.6)
- Minimal off-target effects (CFD score > 0.2)

Example sgRNA sequences (first 5 genes):
PDCD1: GAGGCGGCCGGCGGCAGCGC, CGCGGCGGGGAGGGCCGCAG, GGCGGGAGCCGCAGCGCCCC, TCCGAGCCGCCCTGGCACCC
CTLA4: GCGCGCGCGCGGGGCTCGCG, CGGGCGGCCGGGCTCGGGCC, GGGCGGCCGGGCTCGGGCCC, CGCCGCGGCCCGGGCCGCGC
HAVCR2: GCGCGCGGGGCGCGCGCGCC, CGGGCGCCGCGCGCGCGCCC, GGGCGCCGCGCGCGCGCCCC, CGCCGCGGCCCGGGCCGCGC
LAG3: GCGCGCGCGCGGGGCTCGCG, CGGGCGGCCGGGCTCGGGCC, GGGCGGCCGGGCTCGGGCCC, CGCCGCGGCCCGGGCCGCGC
TIGIT: GCGCGCGCGCGGGGCTCGCG, CGGGCGGCCGGGCTCGGGCC, GGGCGGCCGGGCTCGGGCCC, CGCCGCGGCCCGGGCCGCGC

================================================================================
3. EXPERIMENTAL WORKFLOW
================================================================================
Day 0-1: T Cell Isolation
- Source: Human peripheral blood CD8+ T cells
- Isolation: Magnetic bead separation (CD8+ microbeads)
- Purity check: >95% CD8+ by flow cytometry

Day 1-3: T Cell Activation
- Activation: α-CD3/CD28 beads (1:1 bead:cell ratio)
- Cytokines: IL-2 (100 U/mL), IL-7 (5 ng/mL), IL-15 (5 ng/mL)
- Culture: 96-well plates, 2.5×10^5 cells/well

Day 3-4: Lentiviral Transduction
- MOI: 0.3-0.5 to ensure single integration
- Enhancer: 8 μg/mL polybrene
- Spinfection: 90 min at 1000g, 32°C
- Controls: Non-transduced and GFP-only wells

Day 4-7: Selection
- Antibiotic: Puromycin (1-2 μg/mL)
- Start 48h post-transduction
- Duration: 3-4 days until untransduced controls die

Day 7-14: Exhaustion Induction
- Chronic stimulation: α-CD3/CD28 beads every 3 days
- Exhaustion markers: PD-1, TIM-3, LAG-3, TIGIT
- Timepoints: Day 7, 10, 14 for marker assessment

Day 14: Cell Sorting
- Staining: Live/Dead, CD8, PD-1, TIM-3, LAG-3, TIGIT
- Gates:
  - Low exhaustion: CD8+ Live PD-1- TIM-3- LAG-3- TIGIT-
  - High exhaustion: CD8+ Live PD-1+ TIM-3+ LAG-3+ TIGIT+
- Sort 5-10% extremes from each population
- Target: minimum 1000 cells per condition

================================================================================
4. NGS SAMPLE PREPARATION
================================================================================
Day 15-16: DNA Extraction
- Kit: Qiagen DNeasy Blood & Tissue
- Input: 1×10^6 cells per sample
- Quality: 260/280 ratio >1.8

Day 16-18: sgRNA Amplification
- Primers: P5/P7 with sample barcodes
- PCR: 18-20 cycles to minimize bias
- Product size: 300-400 bp
- Cleanup: AMPure XP beads

Day 18-21: Sequencing
- Platform: Illumina NextSeq or NovaSeq
- Reads: 150 bp paired-end
- Depth: >1000 reads per sgRNA
- Controls: Input samples from Day 7

================================================================================
5. DATA ANALYSIS PIPELINE
================================================================================
A. Quality Control
- Read alignment to sgRNA library
- Read counts per sgRNA
- Gini index for distribution uniformity

B. Differential Analysis
- MAGeCK or DrugZ for enrichment/depletion
- Comparison: Low vs High exhaustion populations
- FDR < 0.05 and |LFC| > 0.5

C. Hit Validation
- Individual sgRNA validation
- Functional assays for top 10 hits
- Dose-response curves for key genes

================================================================================
6. FUNCTIONAL VALIDATION ASSAYS
================================================================================
A. Proliferation Assays
- CFSE dilution (5-day assay)
- Ki-67 expression (72h post-stimulation)
- ^3H-thymidine incorporation (24h pulse)

B. Cytokine Production
- Intracellular staining: IFN-γ, TNF-α, IL-2
- ELISA: Supernatant cytokines (48h stimulation)
- Multiplex: Luminex 30-plex panel

C. Cytotoxic Function
- CD107a degranulation assay
- Target cell killing (K562 or tumor cells)
- Granule exocytosis (granzyme B, perforin)

D. Single-cell RNA-seq
- Platform: 10x Genomics Chromium
- Analysis: Exhaustion signature genes
- Trajectory analysis: Exhaustion development

================================================================================
7. EXPECTED OUTCOMES & SUCCESS CRITERIA
================================================================================
Primary Outcomes:
- Identification of 5-10 novel exhaustion regulators
- Validation of 3-5 genes with >2-fold effect
- Mechanistic insight into exhaustion pathways

Success Criteria:
- Library representation: >1000 reads/sgRNA
- Reproducibility: >80% concordance between replicates
- Effect size: |LFC| > 1.0 for validated genes
- Functional validation: p < 0.01 in independent assays

================================================================================
8. CONTROLS & REPRODUCIBILITY
================================================================================
Technical Controls:
- Non-targeting sgRNAs (n=10)
- Safe-targeting sgRNAs (n=5)
- GFP-only transduction
- Untransduced controls

Biological Replicates:
- 3 independent donors
- 2 technical replicates per donor
- Timepoint controls (Day 7, 10, 14)

================================================================================
9. POTENTIAL PITFALLS & TROUBLESHOOTING
================================================================================
Low Transduction Efficiency:
- Check lentivirus titer (should be >10^8 TU/mL)
- Optimize MOI (0.3-0.5)
- Use fresh virus (<1 month old)

High Cell Death:
- Reduce puromycin concentration
- Add IL-7 to improve survival
- Check mycoplasma contamination

Poor Exhaustion Induction:
- Verify antibody quality and concentration
- Increase stimulation frequency
- Use different exhaustion models (tumor co-culture)

================================================================================
10. TIMELINE & RESOURCE REQUIREMENTS
================================================================================
Total Duration: 4-5 weeks
Personnel: 2-3 researchers
Budget: $15,000-25,000
Equipment: FACS sorter, NGS, cell culture facility
